Ultrasound study reveals stomach risks for patients on popular diabetes drugs

NCT ID NCT06003985

Completed Knowledge-focused Sponsor: Hospital for Special Surgery, New York Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study used a simple bedside ultrasound to check if patients taking GLP-1 agonist drugs (like Ozempic or Mounjaro) have more food or liquid in their stomach before surgery compared to those not on these drugs. Researchers enrolled 354 adults and looked for signs of delayed stomach emptying. The goal is to better understand if these medications increase the risk of complications during anesthesia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GLP-1 agonists (semaglutide, dulaglutide, tirzepatide)
What this could lead to: If successful, this could help doctors know if GLP-1 drugs increase the risk of having food in the stomach during surgery, which could improve safety guidelines.
What could go wrong: This is a small, completed observational study, not a treatment trial. It only measures stomach contents with ultrasound, so it cannot prove cause and effect or change practice on its own.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC ULTRASOUND are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC ULTRASOUND GLUCAGON-LIKE PEPTIDE 1 POINT-OF-CARE ULTRASOUND

Contacts and locations

Locations

Albany Medical Center

Albany, New York, 12208, United States
George Washington University Hospital

Washington D.C., District of Columbia, 20037, United States
Hospital for Special Surgery

New York, New York, 10021, United States
Mayo Clinic

Jacksonville, Florida, 32224, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
University Health Network

Toronto, Ontario, M5G 2C4, Canada
University of Virginia

Charlottesville, Virginia, 22903, United States
Weill Cornell Medicine

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.